Welsis Corp. (WLSS) Financial Statements (2026 and earlier)

Company Profile

Business Address 701 E CATHEDRAL RD
PHILADELPHIA, PA 19128
State of Incorp. WY
Fiscal Year End September 30
Industry (SIC) 80 - Health Services (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2025
Q1
9/30/2025
Q4
6/30/2025
Q3
3/31/2025
Q2
12/31/2024
Q1
9/30/2024
Q4
6/30/2024
Q3
ASSETS
Current Assets
Prepaid expense2,1692,1693,0634,106  
Total current assets:2,1692,1693,0634,106  
Noncurrent Assets
Intangible asset, including goodwill, after accumulated amortization 40,00040,00040,00040,000(15,333)17,333
Goodwill     (15,333) 
Intangible asset, excluding goodwill, after accumulated amortization 40,00040,00040,00040,000 17,333
Other undisclosed noncurrent assets (40,000)(40,000)(40,000)(40,000)  
Total noncurrent assets:     (15,333)17,333
TOTAL ASSETS:2,1692,1693,0634,106(15,333)17,333
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:19,7146,71413,57633,98016,91910,126
Accrued liabilities21,40719,60417,87216,20914,55911,987
Other undisclosed accounts payable and accrued liabilities(1,693)(12,890)(4,296)17,7712,360(1,861)
Debt40,00040,00040,00040,00040,000 
Other undisclosed current liabilities24,89421,78018,98916,78914,77711,987
Total current liabilities:84,60868,49472,56590,76971,69622,113
Noncurrent Liabilities
Long-term debt and lease obligation67,89264,99853,10327,23417,94540,000
Long-term debt, excluding current maturities67,89264,99853,10327,23417,94540,000
Other undisclosed noncurrent liabilities      10,819
Total noncurrent liabilities:67,89264,99853,10327,23417,94550,819
Total liabilities:152,500133,492125,668118,00389,64172,932
Equity
Equity, attributable to parent(150,331)(131,323)(122,605)(113,897)(89,641)(55,599)
Common stock276276276276276276
Additional paid in capital75,51975,51975,51975,51975,51975,519
Accumulated deficit(226,126)(207,118)(198,400)(189,692)(165,436)(131,394)
Total equity:(150,331)(131,323)(122,605)(113,897)(89,641)(55,599)
TOTAL LIABILITIES AND EQUITY:2,1692,1693,0634,106 17,333

Income Statement (P&L) (USD)

12/31/2025
Q1
9/30/2025
Q4
6/30/2025
Q3
3/31/2025
Q2
12/31/2024
Q1
9/30/2024
Q4
6/30/2024
Q3
Operating expenses(15,894)(5,928)(6,507)(22,244)(15,919)(15,688)
Operating loss:(15,894)(5,928)(6,507)(22,244)(15,919)(15,688)
Nonoperating expense
(Other Nonoperating expense)
(3,114)(2,790)(2,201)(2,012)(18,123)(1,664)
Net loss available to common stockholders, diluted:(19,008)(8,718)(8,708)(24,256)(34,042)(17,352)

Comprehensive Income (USD)

12/31/2025
Q1
9/30/2025
Q4
6/30/2025
Q3
3/31/2025
Q2
12/31/2024
Q1
9/30/2024
Q4
6/30/2024
Q3
Net loss:(19,008)(8,718)(8,708)(24,256)(34,042)(17,352)
Comprehensive loss, net of tax, attributable to parent:(19,008)(8,718)(8,708)(24,256)(34,042)(17,352)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: